Krishant Deo completed his PhD in Medicinal Chemistry at Western Sydney University. He then went on to join ANSTO as a Radiochemist, where he worked across commercial and research projects, contributing to the development of both therapeutic and diagnostic radiopharmaceuticals, and medical devices.
His expertise includes manual and automated radiolabelling techniques, with a strong emphasis on method optimisation to enhance process efficiency and reproducibility. Currently based at the University of Sydney’s Brain and Mind Centre (BMC), Krishant is leading initiatives to expand the BMCs radiochemistry platform by enhancing infrastructure, streamlining workflows and supporting collaborative research across multiple disciplines.
He aims to facilitate the transition of radiopharmaceuticals from research to preclinical and clinical applications, supporting advancements in diagnostic imaging within nuclear medicine.
Last week, a new Cima.X 3T MRI instrument was unveiled at NIF’s University of Sydney Node (Clinical Research Facility). Its powerful gradient technology allows for more detailed imaging that is fast
17 September 2025
Researchers have used one of the two 7T MRI instruments in Australia – supported by NIF and the Brain and Mind Centre at the University of Sydney – to map brain control of pain relief from placebo
12 September 2025
Research at the facility is improving patient outcomes by setting new standards for ultra-low dose imaging, which could shape radiation safety guidelines for pregnancy, paediatric and oncology imaging
18 June 2025
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia. The National Imaging Facility supported its developme
16 June 2025